Navigation Links
Scientists Find Way to Dim Cancer Switch
Date:7/1/2008

Research could pave the way for better treatments of certain malignancies

TUESDAY, July 1 (HealthDay News) -- Scientists have discovered that they can use a kind of dimmer switch to stop a "cancer signal" from contributing to the development of tumors.

The findings don't represent a cure, and no one knows if they will even lead to better treatments for cancer. But the research does clear a pathway for scientists to follow as they determine which "switches" they need to turn off to stop cancer in its tracks, said study senior author Dr. Dean Felsher, an associate professor of medicine and oncology at Stanford University School of Medicine.

"You do not have to completely shut off a cancer switch to have a beneficial effect on cancer," he said. "It's a useful improvement over how we've been understanding things."

Normally, cells are programmed to commit suicide if they detect that they're damaged. "The cell says, 'I shouldn't be alive, something is wrong with me, I'm broken.' And it decides to kill itself," Felsher said.

But in some cases, the cells don't automatically kill themselves as they're programmed to do. Instead, proteins send signals that tell the cells to keep growing, said William Tansey, a professor at Cold Spring Harbor Laboratory who studies how tumors develop. "As a result of this push, cancer can develop."

A gene known as Myc is considered a major player in this process. At times, it doesn't cause problems. But its "Jekyll and Hyde" nature can turn it into a villain that sends marching orders to cells, Felsher said.

In the new research, Felsher and colleagues worked with genetically engineered mice to develop a way to slightly adjust the Myc switch instead of turning it on or off.

The study was published in the July 1 issue of Cancer Research.

The researchers found that by turning down the Myc switch, like using a dimmer switch on a lamp, they could shrink tumor cells to normal sizes and restore their ability to die as they're supposed to.

The findings suggest that researchers trying to turn off the signal may not need to go that far, Felsher said. "Before, we thought there were these switches that you had to turn on and off," he said. "Now, we've added a dimmer. To me, that's really exciting."

But he cautioned that there's no treatment based on this approach yet, and fixing the genetic signals won't work for every type of cancer.

However, scientists have implicated the Myc signal in cancers of the immune system and the lungs. "It is estimated that problems with Myc contribute to the cancer-related deaths of as many as 70,000 Americans every year," said Tansey. "So, it's a huge issue."

As for the current study, Tansey said it's an "important step."

"But cancer is a very tough problem," he said, "and a cure will only come once all its facets have been revealed, and the technology required to manipulate the cancers refined."

More information

Learn more about cancer genetics from the National Cancer Institute.



SOURCES: Dean Felsher, M.D., Ph.D., associate professor, medicine and oncology, Stanford University School of Medicine, Palo Alto, Calif.; William Tansey, Ph.D., professor, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.; July 1, 2008, Cancer Research


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists find how neural activity spurs blood flow in the brain
2. Weizmann Institute scientists discover how an injured embryo can regenerate itself
3. Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
4. Scientists ID Enzyme That Allows Dysentery Amoeba to Hide
5. Neuroscientists show insulin receptor signaling regulates structure of brain circuits
6. UF scientists to work with German firm in prostate cancer treatment research
7. Scientists from Granada drastically reduce the wait time for new teeth implant
8. Possible link between different forms of epilepsy found by Carnegie Mellon scientists
9. Scientists Discover Protein Involved in Fat Production
10. Twenty of Americas Most Promising Scientists Selected as 2008 Pew Scholars in the Biomedical Sciences
11. QBI neuroscientists make Alzheimers disease advance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Find Way to Dim Cancer Switch
(Date:5/24/2017)... ... May 24, 2017 , ... If you are thinking of a visit to San ... architecture, October is the perfect time to visit. , Business Architecture Associates is pleased to ... offering for individuals, as a 4-½ day package for individuals, and as 4-½ day corporate ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... most prominent for-profit and nonprofit hospitals and health systems in the nation and ... around their institutions, led professional organizations and been instrumental in developing successful hospital ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dymedix® Diagnostics, ... sensors, announced today it had completed the first phase of building a global ... and rest of world (ROW) authorized dealers specializing in polysomnography accessories. The ...
(Date:5/23/2017)... ... May 23, 2017 , ... Allegheny Health Network and ... Joy D’Achille Center for Women’s Behavioral Health at West Penn Hospital , a ... for women suffering from pregnancy-related depression. Construction of the Center is underway with ...
(Date:5/23/2017)... ... 23, 2017 , ... New England Journal Of Medicine Confirms Viability of Rory’s ... -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt ... http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 in ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... N.Y. , May 22, 2017  Lilac ... treatment Gene-Eden-VIR/Novirin, announces the launch of a ... English, the results of a clinical study that ... year treatment with Gene-Eden-VIR/Novirin in individuals suffering from ... to note that there are no other treatments ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based in ... Parkinson,s disease (PD), has enrolled the first patient in the ... multicenter study involving patients with PD and taking place at ... 9-to-12-month period. The first stage is open label and involves ... include Denver , Boca Raton ...
(Date:5/10/2017)... -- The Corporate Whistleblower Center says, "We are urging ... to call us anytime at 866-714-6466 if they possess ... a substantial scheme to overbill Medicare. We are ... of a medical equipment company if their employer ... practice groups with extra generous incentives to use, or ...
Breaking Medicine Technology: